These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29135996)

  • 1. Clinicopathological and prognostic value of transforming acidic coiled-coil-containing protein 3 (TACC3) expression in soft tissue sarcomas.
    Matsuda K; Miyoshi H; Hiraoka K; Yokoyama S; Haraguchi T; Hashiguchi T; Hamada T; Shiba N; Ohshima K
    PLoS One; 2017; 12(11):e0188096. PubMed ID: 29135996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.
    Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Nakashima K; Shiba N; Ohshima K
    Clin Orthop Relat Res; 2018 Sep; 476(9):1848-1855. PubMed ID: 30024460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer.
    Jung CK; Jung JH; Park GS; Lee A; Kang CS; Lee KY
    Pathol Int; 2006 Sep; 56(9):503-9. PubMed ID: 16930330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of transforming acidic coiled-coil protein 3 expression in non-small cell lung cancer.
    Jiang F; Kuang B; Que Y; Lin Z; Yuan L; Xiao W; Peng R; Zhang X; Zhang X
    Oncol Rep; 2016 Jan; 35(1):436-46. PubMed ID: 26531241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis.
    Nahm JH; Kim H; Lee H; Cho JY; Choi YR; Yoon YS; Han HS; Park YN
    Tumour Biol; 2016 Jan; 37(1):393-403. PubMed ID: 26219896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TACC3 promotes colorectal cancer tumourigenesis and correlates with poor prognosis.
    Du Y; Liu L; Wang C; Kuang B; Yan S; Zhou A; Wen C; Chen J; Wu Y; Yang X; Feng G; Liu B; Iwamoto A; Zeng M; Wang J; Zhang X; Liu H
    Oncotarget; 2016 Jul; 7(27):41885-41897. PubMed ID: 27248823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming acidic coiled-coil protein-3: a novel marker for differential diagnosis and prognosis prediction in endocervical adenocarcinoma.
    Wen YL; Yan SM; Wei W; Yang X; Zhang SW; Yun JP; Liu LL; Luo RZ
    Mol Med; 2021 Jun; 27(1):60. PubMed ID: 34134633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of transforming acidic coiled coil-containing protein 3 strongly correlates with aggressive characteristics and poor prognosis of gastric cancer.
    Yun M; Rong J; Lin ZR; He YL; Zhang JX; Peng ZW; Tang LQ; Zeng MS; Zhong Q; Ye S
    Oncol Rep; 2015 Sep; 34(3):1397-405. PubMed ID: 26133271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of transforming acidic coiled-coil-containing protein 3 (TACC3) reflects aggressiveness of primary central nervous system lymphomas.
    Matsuda K; Sugita Y; Furuta T; Moritsubo M; Ohshima K; Morioka M; Takahashi K; Higaki K; Kakita A
    Pathol Int; 2022 Sep; 72(9):437-443. PubMed ID: 35959857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma.
    Zhou DS; Wang HB; Zhou ZG; Zhang YJ; Zhong Q; Xu L; Huang YH; Yeung SC; Chen MS; Zeng MS
    Oncotarget; 2015 Sep; 6(27):24163-77. PubMed ID: 26219398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of TACC3 in Breast Cancer Associates With Poor Prognosis.
    Song H; Liu C; Shen N; Yi P; Dong F; Li X; Zhang N; Huang T
    Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):113-119. PubMed ID: 27258563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA3 Expression Is a Poor Prognostic Factor in Soft Tissue Sarcomas.
    Haraguchi T; Miyoshi H; Hiraoka K; Yokoyama S; Ishibashi Y; Hashiguchi T; Matsuda K; Hamada T; Okawa T; Shiba N; Ohshima K
    PLoS One; 2016; 11(6):e0156524. PubMed ID: 27249072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TACC3 expression as a prognostic factor in aggressive types of adult T-cell leukemia/lymphoma patients.
    Moritsubo M; Miyoshi H; Matsuda K; Yoshida N; Nakashima K; Yanagida E; Yamada K; Takeuchi M; Suzuki T; Muta H; Umeno T; Furuta T; Seto M; Ohshima K
    Int J Lab Hematol; 2020 Dec; 42(6):842-848. PubMed ID: 32744749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Transforming Acidic Coiled Coil‑Containing Protein 3 Reflects Malignant Characteristics and Poor Prognosis of Glioma.
    Sun Y; Tian Y; Wang GZ; Zhao SH; Han B; Li YL; Jiang CL
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28273854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of TACC3 is correlated with tumor aggressiveness and poor prognosis in prostate cancer.
    Li Q; Ye L; Guo W; Wang M; Huang S; Peng X
    Biochem Biophys Res Commun; 2017 May; 486(4):872-878. PubMed ID: 28336437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative regulation of BRCA1 by transforming acidic coiled-coil protein 3 (TACC3).
    Kim JL; Ha GH; Campo L; Breuer EK
    Biochem Biophys Res Commun; 2018 Feb; 496(2):633-640. PubMed ID: 29355525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic activity of transforming acidic coiled-coil 3 (TACC3) immunohistochemical expression in colon adenocarcinoma patients.
    Brzozowa-Zasada M; Wyrobiec G; Piecuch A; Jasiński D
    Prz Gastroenterol; 2022; 17(3):227-233. PubMed ID: 36127940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TACC3 as an independent prognostic marker for solid tumors: a systematic review and meta-analysis.
    Wang J; Du S; Fan W; Wang P; Yang W; Yu M
    Oncotarget; 2017 Sep; 8(43):75516-75527. PubMed ID: 29088887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TACC3 transcriptionally upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancer.
    Lin ZR; Wang MY; He SY; Cai ZM; Huang WR
    Cell Death Dis; 2018 Jan; 9(2):72. PubMed ID: 29358577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma.
    Hasegawa T; Yokoyama R; Lee YH; Shimoda T; Beppu Y; Hirohashi S
    Oncology; 2000; 58(1):66-74. PubMed ID: 10644943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.